HLS Therapeutics Secures New CAD-Denominated Credit Facility to Enhance Financial Flexibility
HLS Therapeutics Inc. has secured a new CAD $107 million credit agreement with National Bank of Canada, replacing its previous agreement and providing the company with increased financial flexibility to support its operations and strategic initiativ…
2 minutes to read
